rs104893992
Variant summary
Our verdict is Pathogenic. Variant got 18 ACMG points: 18P and 0B. PM1PM2PM5PP3_StrongPP5_Very_Strong
The NM_001024630.4(RUNX2):c.673C>T(p.Arg225Trp) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant was absent in control chromosomes in GnomAD project. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. R225L) has been classified as Likely pathogenic.
Frequency
Consequence
NM_001024630.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 18 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
RUNX2 | NM_001024630.4 | c.673C>T | p.Arg225Trp | missense_variant | 5/9 | ENST00000647337.2 | NP_001019801.3 | |
RUNX2 | NM_001369405.1 | c.631C>T | p.Arg211Trp | missense_variant | 3/7 | NP_001356334.1 | ||
RUNX2 | NM_001015051.4 | c.673C>T | p.Arg225Trp | missense_variant | 5/8 | NP_001015051.3 | ||
RUNX2 | NM_001278478.2 | c.631C>T | p.Arg211Trp | missense_variant | 3/6 | NP_001265407.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
RUNX2 | ENST00000647337.2 | c.673C>T | p.Arg225Trp | missense_variant | 5/9 | NM_001024630.4 | ENSP00000495497 | P4 |
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD4 exome Data not reliable, filtered out with message: AC0 AF: 0.00 AC: 0AN: 1452924Hom.: 0 Cov.: 28 AF XY: 0.00 AC XY: 0AN XY: 723512
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Cleidocranial dysostosis Pathogenic:5Other:1
Pathogenic, criteria provided, single submitter | clinical testing | Center of Excellence in Genomics and Precision Dentistry, Faculty of Dentistry, Chulalongkorn University | - | The heterozygous c.673C>T (p.Arg225Trp) in RUNX2 gene was identified in a patient with cleidocranial dysplasia. This variant has been reported in a CCD patient in the former name of RUNX2, CBFA1 (Quack I et. al., 1999). - |
Pathogenic, no assertion criteria provided | clinical testing | Bioscientia Institut fuer Medizinische Diagnostik GmbH, Sonic Healthcare | - | - - |
Pathogenic, no assertion criteria provided | literature only | OMIM | Nov 01, 1999 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Victorian Clinical Genetics Services, Murdoch Childrens Research Institute | Jun 24, 2022 | Based on the classification scheme VCGS_Germline_v1.3.4, this variant is classified as Pathogenic. Following criteria are met: 0103 - Loss of function and gain of function are known mechanisms of disease in this gene and are associated with cleidocranial dysplasia (MIM#119600) and metaphyseal dysplasia with maxillary hypoplasia with or without brachydactyly (MDMHB; MIM#156510), respectively. MDMHB is caused exclusively by inframe exon duplications (OMIM, PMID: 29891876, PMID: 23290074). (I) 0107 - This gene is associated with autosomal dominant disease. (I) 0115 - Variants in this gene are known to have variable expressivity with intrafamilial variability (OMIM). (I) 0200 - Variant is predicted to result in a missense amino acid change from arginine to tryptophan. (I) 0251 - This variant is heterozygous. (I) 0301 - Variant is absent from gnomAD (both v2 and v3). (SP) 0501 - Missense variant consistently predicted to be damaging by multiple in silico tools or highly conserved with a major amino acid change. (SP) 0600 - Variant is located in the annotated runt domain (DECIPHER). (I) 0702 - Other missense variants comparable to the one identified in this case have strong previous evidence for pathogenicity. These alternative changes (p.(Arg225Gln), p.(Arg225Leu)) have been reported as pathogenic, and/or observed in individuals with cleidocranial dysplasia (CCD) (ClinVar, PMID: 20702542). (SP) 0801 - This variant has strong previous evidence of pathogenicity in unrelated individuals. This variant has been reported several times as pathogenic, and observed in individuals with CCD (ClinVar, PMID: 31548836, PMID: 28738062). (SP) 1208 - Inheritance information for this variant is not currently available in this individual. (I) Legend: (SP) - Supporting pathogenic, (I) - Information, (SB) - Supporting benign - |
Pathogenic, criteria provided, single submitter | clinical testing | 3billion | Mar 22, 2022 | Same or different nucleotide change resulting in same amino acid change has been previously reported as pathogenic (ClinVar ID: VCV000009303 ). Functional studies provide strong evidence of the variant having a damaging effect on the gene or gene product (PMID: 10521292). A different missense change at the same codon has been reported as pathogenic/likely pathogenic with strong evidence (ClinVar ID: VCV000009302, PMID:10545612,19767586). In silico tool predictions suggest damaging effect of the variant on gene or gene product (REVEL: 0.935>=0.6, 3CNET: 0.926>=0.75). It is not observed in the gnomAD v2.1.1 dataset. Therefore, this variant is classified as pathogenic according to the recommendation of ACMG/AMP guideline. - |
not provided, no classification provided | literature only | GeneReviews | - | - - |
not provided Pathogenic:2
Pathogenic, criteria provided, single submitter | clinical testing | CeGaT Center for Human Genetics Tuebingen | Jan 01, 2020 | - - |
Pathogenic, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Jan 21, 2024 | This sequence change replaces arginine, which is basic and polar, with tryptophan, which is neutral and slightly polar, at codon 225 of the RUNX2 protein (p.Arg225Trp). This variant is not present in population databases (gnomAD no frequency). This missense change has been observed in individual(s) with cleidocranial dysplasia (PMID: 10521292, 31548836). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 9303). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt RUNX2 protein function with a positive predictive value of 80%. Experimental studies have shown that this missense change affects RUNX2 function (PMID: 10521292). This variant disrupts the p.Arg225 amino acid residue in RUNX2. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 10545612, 24222232, 24634175). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at